At Nuvothera, Rx Derma Veterans Develop OTCs For Serious Skin Conditions
Executive Summary
Firm launched Prosoria in 2018 as a four-product topical line for inflammatory autoimmune disease psoriasis containing salicylic acid 3% combined with turmeric and other botanicals. CEO Arthur Clapp says firm will launch turmeric supplements and plans adding products for acne, eczema, warts, nail fungus and rosacea.
You may also be interested in...
Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval
Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.
Investment Group Focused On Natural Wellness Acquires Plant-Based Protein Pioneer Vega
WM Partners acquires Vega plant-based nutrition brand from Danone with plans to leverage its operational experience to grow the brand and tap Vega’s distribution to expand market for its existing portfolio of brands.
Final Quarter Of P&G CEO Taylor’s Tenure Could Become Stormy With Headwinds From Rising Costs
P&G’s health care sector’s net sales grew 18% in its latest quarter. Continued growth across its sectors is critical in the face of expected $1.8bn in headwinds from commodity and freight costs in its FY2022.